After two weeks of up days to close the year, market decided to take a correction on the first day of the new year.

Fortunately for me, six of my stocks were up today with the other three down slightly.

The biggest winner today is again $KNDI. At first, it opened down a bit and then it rallied hard all day until the last hour when profit-taking brought it down a bit.

Notice that price continued to stay above the 79 & 89 MA lines on the 5 min. chart above..

From the weekly chart,below $KNDI looks very strong.

Notice that this week bar completely trade outside the upper band of the Bollinger band.  I’ve reason to believe that $KNDI upgraded to NasdaqGS listing today opens the door for institutions to buy $KNDI.

$GALE also climbed back up above $5 today so that was another good beginning.

If you look at all the MA lines and indicators, they are all pointing up.

The weekly chart also looks strong for $GALE.

With the $ADX beginning to trend up, I see there are still room for the momentum indicators to go up before they are being labeled as overbought.

$KGJI bounced today and that was a good sign.  From the daily chart below, you could see that price action was forming a symmetrical triangle b/w the downtrend line and the 79 & 89 MA lines.

I expect a pop to the upside soon.  Perhaps, it is now $KGJI turn to run hard. If it does, It will surely propels my portfolio to higher ground since $KGJI is my third largest position right now.

Thanks to $KNDI, my portfolio opens to the new year with a bang!  An auspicious sign indeed.

Current holdings:

KNDI, LRAD, KGJI, CERS, INO, GALE, XONE, AMRN, TINY (full speculated).

From my other account:

$PHOT continues to head much higher.

If there are shortage of legal pot in Colorado, I expect to see $PHOT reach a dollar inside three months.  I will not be surprised if the magnitude of the shortage in legal pot exceeds everyone expectation.

My 2 cents.

 

Comments »

Let me start off this post with a quote from Calvin Coolidge:

Nothing in this world can take the place of persistence. Talent will not: nothing is more common than unsuccessful men with talent. Genius will not; unrewarded genius is almost a proverb. Education will not: the world is full of educated derelicts. Persistence and determination alone are omnipotent.

In hindsight, we know the market has marched on ahead in an upward, albeit in a wavy manner, direction in the year of 2013; nevertheless, my personal path to achieving stock market gain was an uphill battle fraught with potholes and slippery slopes.

Potholes I fell into in 2013:

• $ECTY- large losses (company filing bankruptcy)
• $ETRM- medium losses (failed Phase III study)

Slippery slopes I encountered:

• $AMRN- large losses (you know the story)
• $USU- large losses (I bailed before the reverse split and the ensuing gigantic rally afterward)
• $SZYM- medium losses (whipsawed from over-trading in downtrend market)
• $APRI- medium losses (holding against a downtrend and gave up before the recovering year-end rally)
• $NCTY- medium losses (mistake in betting big on a thinly traded and small float stock)

Despite the multiple losses I endured from the above trades, they were all managed losses.  In other words, I didn’t let these losses get out of control by averaging down.  While some of the losses were large, it was because I made the initial large bet to begin with and not as a result of averaging down   While I had suffered mental frustration with these controlled losses (who wouldn’t?), I did not wallow in self-pity, I got back up and moved on.  I am persistence because I know I can get my money back as long as I’ve my capital intact.  It is a matter of being perseverance in searching for the stocks that will give me back the money and more.

Sidebar: It is extremely important that you manage your losses according to sound money management principle.  If I had not managed my losses, I would not be able to recover no matter how persistence I could be.  The rule of trading world is that you MUST protect your capital to fight another day.  My trading style is focused on finding the hi-beta stocks that will give me the jackpot I’m looking for; thus, I know I’ve to take some hits from time-to-time.   While this has been my endeavor, I’m still developing and evolving as a trader; therefore, trading mistakes were made (as in $SZYM, $APRI, and $NCTY) and I’m learning from them.

Having covered my losses, let’s go over my wins!

• $KNDI- very large gain
• $INO- very large gain
• $LRAD- large gain
• $GALE- medium gain
• $GOGO- medium gain
• $NUGT- medium gain
• $CERS- medium gain
• $CLIR- medium gain

My biggest win in 2013 was $INO. Upon hearing about $INO, I did my research but was initially skeptical since stock price had been trading below below $1.00 for first half of the year. But when price started to climb to near dollar, I began to take notice of a possible breakout.  Then the proliferation of positive preclinical news came into the foreground.  With price advancing over $1, I began to average UP.  Not only that, I kept averaging up on each bounce up after a brief consolidation; by the time price reached $3, I was sitting on such huge gain it would be foolish not to lock in profit especially when I knew the preclinical trials result was still a long way to human trials.  In other words, the price went up too far too fast.  I exited about 80% of my position at an average price of $2.75 and the rest in mid-to-low $2.xx.  It was a very profitable trade.

$KNDI was a trade I found after I got burned by $ECTY.   Despite the punch on the stomach (figure-of-speech), I refused to give up my beliefs in the potential of EV.  $TSLA has pretty much convinced me that EV does have a place in our society after my few failed attempts to short $TSLA with put option.  My shorting $TSLA was based on simple assumption that the market cap had gone too far ahead of the fundamental; however, when I saw the actual Tesla Model S in the showroom and the elegant and simple design of the electric motor compared to the complicated ICE (internal combustion engine); I was sold on the concept of EV.

Tesla high-end car succeeds because Elon Musk knows that the top 10% of the wealth will buy the car if it looks nice and function perfectly.  And when Consumer Reports magazine gave the Tesla Model S the highest score in its Ratings: 99 out of 100 back in July, I knew then that EV is here to stay.

However, the only problem is that if $TSLA, the only EV with a much longer driving range on a single charge than its cheaper competition, already captured the top 10% wealth; who will buy the cheaper EV models with shorter range?  Hence my belief that $ECTY was the key solution to expanding the EV market for cheaper EV models.  Little did I know that $ECTY was so badly managed, despite its being the company chosen by US Department of Energy to spearhead the charging station project, that I promptly lost 80+% of my investment in a single day after $ECTY made an announcement of its major issues.

Still very much believing in the EV potential and that $ECTY mismanagement did not equal to EV failure, I kept on researching for the next EV stock to speculate.

Then I found $KNDI.

What tickle me the most about $KNDI is that it is not selling directly to the consumer which I know will not work because of the range anxiety.  Without the proliferation of charging station everywhere, it will be difficult for an accelerated growth in consumer buying.  But $KNDI is offering a solution that automatically solves the range anxiety issue; not only that it also solves the charging station issue as well.  By embracing the concepts of car-to-go and zipcar except that the EV must be returned to the garages strategically located at multiple fixed locations for recharging purposes, $KNDI found an optimal solution to the range anxiety and battery dilemma in the EV market.  What is more important is that consumers do not need to buy the car but simply rent them for a very low price that is cheaper than hiring a taxi.

At the time when I found $KNDI, price was trading around $5 after it came back down from a quick run to $8.  Because of the secondary offering after the spike to $8, the stock was mercilessly attacked by the short.  On top of that, the uncertainty from having to  wait for the new China EV subsidies that had yet to be announced only added fuel to the short.

Hmmm….

Instead of going away like most everyone because of the history of bad blood from some stock scams from China, I began to see this as an opportunity to buy when it was still cheap.  After reading all the due diligence performed by other $KNDI believers and compared them to those who short, my own analysis prompted me to start building a position in $KNDI.  While I was building my position, $KNDI was trading in a tight range b/w $4.50 and $5.50.  Plenty of patience was required on my part.

The good thing about having a large position on a stock is that you tend to watch its trading pattern very closely on a daily basis.  And when price crossed back over the 79 & 89 MA lines to the upside, I could sense a coming rally.  Thus, I decided to buy a boatload of Dec $7.50 call to supplement my stock position.  As luck would have it, right after I had bought the options, the stock became a runner the very next day.  When price reached $9 and started to reverse direction, I had the good sense to lock in profit on 70% of my option trades.  The rest I gave back to the market when it expired worthless.  Having exited most of my option trades, I decided to reduce my stock position as well to lock in profit.  My swing trade mentality was in full-swing.

From then on, I bought and sold $KNDI to supplement my core position without success for two months.  In fact, my realized gain was slowly leaking thru the multiple whip-saws from my trading in-and-out of the trading position. And then the news of Geely announcing to the public that it would have the EV version of the London black taxi available in five years.  That was all I needed to hear to double-down on $KNDI.  After the Geely announcement, I knew it was time to stop swing trading $KNDI.  Why did I feel that way?  It was the subtle message from Geely that it is committing to the EV market; otherwise, why made such a bold statement?  With $KNDI being in a 50/50 joint venture with Geely for the sole purpose of building EV cars, $KNDI has a LOT to gain from this announcement.

Again, I was correct in my assessment; thanks to my double-down on $KNDI, my gain was quite phenomenon in the last week in 2013.

Sidebar: Performing daily homework in researching for potential runner is the discipline that keeps me going forward.  And I’m not just talking about picking up stock ’cause so and so says he/she is buying.  I need to analyze the fundamental and decide if the stock has the “story” as well as a chart pattern to support it before I venture in.  If you are willing to do YOUR own analysis and homework on a stock regardless where you hear it from, the stock will become YOUR own pick; not someone pick.  And you will trade this stock according to YOUR trading strategy; not someone’s.  The benefit of doing YOUR own analysis is that you will LEARN from your mistake and grow as a trader. Otherwise, you will never grow as a trader if all you do is to follow someone pick.

My purpose of writing about my thought process in my $KNDI and $INO trades is to emphasize the importance of doing your own research.  By doing your own research, you will get a much better sense of the stock and how it is trading.  If you are the more risk-taking type, you may even augment your position size like I’ve done with $INO and $KNDI.

$GOGO came to mind as another perfect example.  After The Fly made the call on $GOGO, I began to research the stock and like what I saw.  Then I started to build up my position based on my analysis of the chart-pattern.  In other words, I began to trade $GOGO irrespective of what The Fly was doing with his $GOGO position.  If you do your own homework, you make the stock your own and you only have yourself to blame if the stock doesn’t perform.  This is the ONLY way you can learn and grow as a trader.

To conclude my post, despite having my portfolio down in the middle of the 2013 due to my losses mentioned above, I was able to climb back out of the hole and ended the year in a very positive note.

Due to my evolving as a trader, I am now focused on shepherding my current portfolio of nine hi-beta stocks for the potential run-up in 2014.  Holding on to a winning position for as long as I can is the only way to make the big bucks.  I like to see all nine of my stocks, if possible, to run the way $LNG and $CLDX ran in 2013 (both of these stocks I used to own but got out way too early!)

Current holdings:

$KNDI – I believe $KNDI will dominate in China with its business model of selling to the car-sharing garages.

$LRAD – I believe its newly minted mass-notification technology will dominate the replacement of the obsolete bullhorn speaker notification system worldwide.

$KGJI- I believe that the new wealth in China will increase consumers’ crave for 24K gold products that $KGJI will have blow-out quarter-to-quarter revenues that price has no choice but to keep going up.

$CERS- I believe that FDA will approve $CERS blood purification system.  Why?  ’cause they are selling them to Europe already without any issues.

$INO- I am “betting” that $INO has finally tweaked its synthetic DNA enough to work in human.

$GALE- I believe its Astral drug will sell well quarter after quarter.  I’m also “betting” that its NeuVax breast cancer treatment will succeed.

$XONE- I believe its 3D manufacturing machines will become dominant in the manufacturing sector.

$AMRN- I believe FDA will meet $AMRN half-way on its Vascepa label expansion.

$TINY- I believe that its portfolio of private investment in multiple nanotechnology companies will take fruition in 2014.

I wish everyone a happy and prosperous New Year!

My 2 cents.

Comments »

Market decided to take another breather day by staying neutral once again.

Stock Gawd has favored me today once again as well.  As I’ve predicted last Friday, $GALE was either going to take the baton as a runner or it was going to run concurrently with $KNDI.  Well, as luck would have it, the latter was the ones happened today.

Why would $GALE continue to head higher?  I see there are two major catalysts that are favoring $GALE in the coming year- its rapid relief drug Abstral for breakthrough cancer pain and its pipelines of breast cancer treatment drug- NeuVax.

– $GALE management has the good foresight to secure the right to sell Abstral in the US.  And by doing so, $GALE may have hit the jackpot when no one is looking.  Take a look at $INSY. INSY Therapeutics Inc. is the major competitor to $GALE’s Abstral since it is selling their own version of Fentanyl sublingual drug similar to Abstral.  Yet, $INSY carries a market cap of $870 million compares to $GALE $507 million after today close.  While $INSY has other pipelines in the work, its main revenue generator, I believe, is its Fentanyl sublingual drug.

– With proper marketing, I believe $GALE can take market share away from $INSY giving enough time.  Thus, by its Abstral product alone, $GALE has the potential to be worth at least current market cap before counting its breast cancer NeuVax treatment.

– If there are any positive news from its NeuVax trial results, price has no where else to go but up and up.

This is why I’m not surprised to see $GALE bounce higher today.  Friday chart pattern told me it would go higher and it did.

Take a look at the daily chart below:

Price has taken out the 12/5 high at $4.78 with volume higher than the last five days.  Momentum indicators below haven’t shown to be overbought yet; thus, I’m expecting this breakout to go higher this week.

Now look at the monthly chart below:

Whoa! Did you see the breakout from the high of Dec 2010 at $4.08?  From a long-term perspective, $GALE has broken out of a three years high and the chart looks like it is going to go much higher.

Meanwhile, $KNDI did not disappointed.  Instead of handing the baton to $GALE, it ran side-by-side with it.   In the morning, I was struck by a strong urge to sell some $KNDI to lock in profit.  It was my swing trade mentality that kept urging me.  To counter this urge, I’ve to remind myself about the lost opportunity I had with $LNG.  Back in the early days when $LNG was trading around $5 bucks, I loaded up big and gave way to my urge and locked in profit around $7.  After that, due to volatility, I never got back in.  $LNG is now trading at $43!  With $LNG in mind, I was able to sit on my hands.

I’m sure it will be a wild ride here.  I’m expecting to see some profit-evaporation due to volatility and profit-taking.  And I’ll need to remain steadfast in holding my $KNDI position ’cause I know that if I try to swing trade, I’m going to mess up a good long-term trade here ’cause you will never know when the next surprise rally will hit this stock.

From the daily chart above, $KNDI gapped up nicely but ended a red bar.  That may not mean anything but room must be given for some correction and profit-taking.  I’m just satisfied that the last few days have helped my portfolio to regain higher ground.

Asides from $KNDI and $GALE, $AMRN also popped back up today.  I’m a firm believer that there is a possibility for FDA to reconsider $AMRN position and perhaps will meet $AMRN half-way in some fashion.  Furthermore, I’m impressed by the citizen petition that was submitted to the FDA by the grassroots organization called EPAdruginitiative.com.  Read the petition and you will understand why I decided to add more 2014 March $5 call option at 12 cents to increase my bet.  The way I see it, the reward far exceeds the risk many-times over if FDA turns a favorable corner.  If not, I won’t regret my bet since the potential loss is definitely manageable for me.

From the daily chart above, you can see a healthy bounce with price closing above the 5 & 15 MA lines.

I spoke too soon on Friday regarding $XONE.  Today, $XONE flip-flopped with $DDD and $SSYS with the former going down and the latter going up!  Oh well.  Nevertheless, I’m in the money with $XONE and is holding this one thru 2014.

$LRAD, $CERS, and $KGJI were not performing well today but its smaller corrections were totally masked by the gains from $KNDI, $GALE, and $AMRN.  Huge gains from $KNDI has given my portfolio another healthy gain.

Due to $KNDI continued price increase, it has become the largest position in my portfolio with $LRAD coming in second.

Current holdings:

KNDI, LRAD, KGJI, CERS, INO, XONE, GALE, AMRN, TINY (fully speculated).

I also increase my stake in $PHOT in my other account (the same one where I trade options) in preparing for Colorado to open its door to legal pot starting Jan. 1st, 2014.  Per the article here: Colorado To Blaze Marijuana Tourism Trail In 2014 With Legal Pot Shops, it stated:

Whether there will be enough pot to meet the expected rush next year is another matter altogether. State laws impeded efforts to ramp up production before Jan. 1, meaning it could take several months for supply to catch up with demand.

The way I look at it, I’m expecting to see a lot of will-be marijuana growers lining up in front of $PHOT door looking for financing to start their pot farming on Jan. 1st.  Hence my adding more to $PHOT today.

My 2 cents.

Comments »

And the market continued to reach new height to make way for 2014…

Meanwhile, $INO has another fantastic run-up day.  Compared to the last two run-up in the 2nd half of 2013, this run-up is based entirely on expectation instead of news released from the company.  The thing about expectation is that you never know when the run is over.  In other words, we never know where the price point for this renewed expectation.

From the daily chart, you can see that the 79 & 89 MA lines are in an uptrend.  Not only that, these two magical lines are able to support the corrections from the last two run-ups.  For a biotech company to test the previous highs of the last two run-up within a 5-month periods, I’ve to say that $INO has a lot of believers as well as investors who want to see $INO succeeds for the benefits of the human race.  Make no mistake, if the trial result in mid-2014 proves positive, the implication is a disruptive bio-technology that will surely revolutionize vaccines technology.  Not to mention the positive expectation on the multiple pipelines $INO is currently working on.

Can $INO synthetic vaccines work this time when so many others have failed?  Will they finally get it right this time to merit a positive trial result?  Could past failures point $INO to the right path in making synthesis vaccines to work in human?  We will soon find out by mid-2014 with their cervical cancer trial result.  Previous run-up had been based on fantastic news from positive preclinical results on mice.  And a jump from mice to human will require a lot of “tweaking” in the labs to make it works on human.  I’m crossing my finger that the $INO has finally tweaked its synthesis vaccine to the point that it will work on our human body.

Having said that, $INO is still a speculative bet.  A bet that if won, a blast-off in price will result; and if failed, be prepared to say good-bye to your investment.  And that is why I’m investing only a mid-size position in comparing to my previous big bet on the first run back in August.  With a mid-size position, I no longer need to watch it like a hawk and be quick on the trigger.  I can just let it ride amidst the volatility.

Take a look at the monthly chart above, price has already climbed above all MA lines. Even the 89 MA is now beginning to point up.  It looks like price is getting ready to make history next year, the year of 2014.

For all intent and purpose, all the stocks in my portfolio are chosen for its potential explosive run-up in 2014.

$KNDI did well today by heading higher albeit only 2.63%.  As long as price can continue its momentum to the upside, I’m happy.

I like the fact that the 5 MA line is now pointing back up.  There is a lot of potential for $KNDI in 2014.  All we need to hear next year is the completion of more and more car-sharing garages in multiple cities in China.  I truly believe the business model of selling the EV to car-sharing garages as opposed to consumers directly is the KEY to getting EV out on the roads.  I’m very confident that $KNDI (by partnering with Geely- one of the largest car manufacturer in China) will succeed in leaps and bounds in this car-sharing direction.

$XONE continued to head higher today and I like to see it take out $100 next year.

Price has finally bounced away from the 79& 89 MA lines with the 5 MA pointing up.

$GALE is another speculative bio-tech I like that may flourish in 2014.  Today small increase continued to support the current consolidation instead of developing a downward trend.

The underlying tone, as can be seen by the two momentum indicators below as well as the 5 MA line starting to point up, is still bias on the long side.  I can see price pop either into the year-end or early next year.

Thanks to $INO, $KNDI, $XONE, and $GALE, my portfolio has another healthy gain today.

Current holdings:

LRAD, KNDI, KGJI, CERS, INO, XONE, GALE, AMRN, TINY (fully speculated).

My 2 cents.

Comments »

Without a doubt, X’mas rally has been validated by another fine up day on X’mas Eve.

$KNDI started off with a big bang and traded as high as $8.57 before settled down to close at $8.00.

There is no question that the downtrend line has been breached and price is now looking to head higher from here.  While price did not close near the high, it did close up 4%.  This is good enough for me.  When you look at it from a long-term perspective, it really doesn’t matter if price closes near the high or not ’cause you are looking for a much higher price than today trading range.  Therefore, all I care is that the uptrend is intact.

Next, $CERS continued to surge higher.

Price is now very near the downtrend line and it will not take much to walk over it later this week.  I expect to see much higher price in 2014 simply because I’m confident that they can get FDA approval to sell their products in the U.S.  (Be aware that my confidence in $AMRN has taken me to a cleaner the last few years; in other words, I can be very wrong sometimes.)  $CERS products have been selling in Europe without incident so I don’t see any issue that the FDA may find in $CERS U.S.  trial results   With approval, this stock will take off like a ….

I was glad to see $KGJI bounced today ’cause I needed to see price bounced off the 89 XMA line.

Price action closed above both 79, 89, and 5 MA lines today with both momentum indicators continued to point up.  Let’s see if price can bounce higher from here.

$INO did not disappointed since price moved higher and away from the resistance and now support line at $2.38.

Next target is $2.90 and after that $3.0.

$XONE had a crazy day when price dropped an astounding $5+ from today high.  Miraculously, price recovered to close only .$0.52 or -.88% as opposed to  around -5% for $DDD and $SSYS.

I chose $XONE for its focus on manufacturing angle; and it is probably because of this angle that $XONE survives the downdraft on 3-D printing companies today.

Both $GALE and $AMRN had a negligible correction that did not warrant me to put up a chart for review.

Overall, thanks to $KNDI, $CERS, $KGJI, $LRAD, and $INO, my portfolio has a healthy gain today.

Current holdings:

LRAD, KNDI, KGJI, CERS, INO, XONE, GALE, AMRN, TINY (full speculated)

My 2 cents.

Happy Holiday and thanks for reading my blog!

Comments »

Market continued to move higher today. One more day of convincing nonbelievers that X’mas rally is for real.

But in my case, my portfolio had a Santa and a nonbeliever working together today; one cancelled the other.

$LRAD, $KGJI, and $AMRN (nonbelievers) corrected but thanks to $INO, $XONE, and $KNDI (Santa), my portfolio was practically unchanged.

$KGJI gave back a chunk of gain from Friday but at low volume; thus, this one still had a lot of nonbelievers to work off.

Notice that price landed right on the 89 XMA line. I like to see price bounces back up tomorrow.  Since $KGJI is a fairly large position, the give back is substantial.

Fortunately, $XONE bounced hard today.

Notice how price action took out the previous pivot-high from Dec 4th at $57.65.  This is a very bullish bounce.

$INO also had a strong breakout today.

Notice how price action took out TWO resistance lines today- one from Nov 25th at $2.24 and $2.38 from Oct 8th.

Although $KNDI was up today, it was still struggling to stay above the downtrend line.

Price still stays above the 15 MA line and the 79 & 89 are still pointing up; so the overall trend is still up.

$AMRN was down today but this was to be expected after a big 25% up day from last Friday.

Price is still above the Friday low which I see at a positive sign.

Meanwhile, $CERS continued to march ahead.

Price is now closing above all MA lines.

$LRAD correction today confirms that it is now in a consolidation phase b/w $2 and $1.8x waiting for news to bounce.

Any big order news from China will drive this one up over $2 very quickly.  Meanwhile, patience is required.

$GALE is also consolidating in a tight range b/w $4.20. and $3.85.

Notice how the 5 MA line is beginning to turn up.  Let’s see if there is a bounce this week before the year end.

Since I believe in $TINY to be relevant only in 2014, it is still worthy of mentioning here.

Based on the weekly chart,above, today bounce may signify a bottom here at around $3.00.

While my portfolio is at breakeven point today, the underlying strength is strong in my opinion.  Thus, I’m looking forward to the weeks ahead.

Current holdings:

LRAD, KNDI, KGJI, CERS, INO, XONE, GALE, AMRN, TINY (fully speculated)

My 2 cents.

Comments »

The Dow Jones Industrials closed at historical high while the SP500 closed below but still bullish nevertheless.

Meanwhile, I had three stocks that recovered strongly that helped my portfolio bounced solidly today.

$AMRN bounced 25.79% higher, $KGJI 15.38%, and; $CERS 4.97% higher.  With the exception of $GALE, the rest bounced slightly.

Fate had it that $NUGT stopped me out yesterday that prompted me to look at $AMRN; otherwise, I would be watching $AMRN bounce with pain in my heart since I had sat in this one for years with every ounce of conviction that I could muster.  I’m curious if we are seeing the bottom of $AMRN here.  While the FDA is merely delaying the decision that was due today; it opens the possibility that it may consider giving $AMRN some rope for its Vascepa label expansion.  At this stage, any rope, even for an inch, will open the door for $AMRN to recover from its current situation.

While today bar chart didn’t close above the last resistance at $2.07, it is not that far off from it.  Let’s see if there are enough believer going forward to buy the price back up to the Jan 15 decision day.

$KGJI strong green bar coupled with high volume and turning up of the momentum indicators all points to a future rally here.

Notice that today price action closed above all the MA lines.

The weekly bar above is even more bullish. See how price closed above the 89 XMA as well as the 5 and 15 MA lines?  From the weekly chart, this speaks much louder than the daily chart.  The bounce is in and $KGJI is heading higher from here.

$CERS is definitely bouncing away from the support line at $5.7x.

One look at the chart and you can expect to see the bounce will continue on.  Both momentum indicators are turning up with high volume.

Since $KGJI and $CERS are my third and fourth largest position in the portfolio with $AMRN being 50% in size relatively, I expect any strong rally from here for these three stocks will carry my portfolio to higher ground.  Not to mention that the rest of my stocks all have the potential to do the same in 2014 and beyond.

Current holdings:

LRAD, KNDI, KGJI, CERS, XONE, INO, GALE, AMRN, TINY (fully speculated).

Btw, giving the Dow Jones Industrials is making new historical high today, I congratulate everyone who is loaded on equity.  For those who is still waiting on the sideline, you know that price inflation will eventually wipe you out despite the government stance that there is no inflation.  The stock market is a major source of protection against inflation in a growing economic environment.  In other words, you are never safe in heavy cash position while the market continues to head higher.  The universe is always expanding, so is the market.

My 2 cents.

Comments »

Market tried to correct but ended the day nearly neutral.

$NUGT gapped down and I placed a stop below intra-day low instead of outright getting out.  Nope, no luck.  I was stopped out anyway.  I took my losses and moved on.  With the newly released fund, what should I buy?

Then I started looking at $AMRN again. Are you crazy?

What if for some exotic reason the FDA decides to offer some half-way measured approval for Vascepa?  What if…  What if…

Enough what if already; thus I bought back $AMRN with the available cash just to shut myself up.

Now, if $AMRN shoots up tomorrow (long shot), then I’ve $NUGT to thanks for.  Without $NUGT stopping me out today, I wouldn’t have bought $AMRN.  OK, enough talking on my part, let’s roll the dice!

I was hit hard today by $KNDI and $KGJI; thus despite an up day for $LRAD, I’m still under water a bit today.

Nevertheless, for the long-term hold on most of these hi-beta stocks, today hiccup is just your standard cup of tea.  Nothing to sweat about.

Current holdings:

LRAD, KNDI, KGJI, CERS, XONE, INO, GALE, TINY, AMRN (fully speculated)

My 2 cents.

Comments »

Market began by trading down and then spiked up big time in mid-day.

Unfortunately, my portfolio wasn’t able participate in this relative giant rally.

I did change the overall structure of my portfolio by reducing $CERS, $GALE, $TINY to buy $INO.

From the chart, $INO looks like it is going for another test against the resistance at $2.24.  Price is now above all the MA lines.

$NUGT suffered today due to the huge rally in equity.

If it takes out the support at $25.2x, I will have to cut my losses once again.

Current holdings:

LRAD, KNDI, KGJI, CERS, XONE, INO, GALE, TINY, NUGT and 1% cash.

My 2 cents.

Comments »

After a jump yesterday, the market decided to take an early break by taking a minor correction.

Meanwhile, I used the released cash to buy back some $XONE and $GALE I sold yesterday.

Thanks to $LRAD having an up day, it took my portfolio higher today despite some minor dips from $CERS, $KGJI, and $NUGT.

The chart looks bullish overall, You can see that the bounce takes the price above the 5 and 15 MA lines.

The weekly chart looks even better.

See how the 5 MA line is moving higher with price closing above it?  Most important of all, price remains above the breakout line.

$KNDI remained positive although percentage was small.

What I care most about is that price remains above the downtrend line.

Current holdings:

LRAD, KNDI, CERS, KGJI, TINY, GALE, XONE, NUGT and 2% cash.

My 2 cents.

Comments »